Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates

Core Viewpoint - Hologic reported quarterly earnings of $1.03 per share, exceeding the Zacks Consensus Estimate of$ 1.02 per share, with revenues of $1.01 billion, surpassing expectations by 0.34% [1][2]. Financial Performance - The company has surpassed consensus EPS estimates three times over the last four quarters [2]. - Hologic's revenues for the quarter ended March 2025 were$ 1.01 billion, compared to $1.02 billion a year ago [2]. - The earnings surprise for the recent quarter was 0.98%, with the company expected to post earnings of$ 1.02 per share but actually reporting $1.03 [1][2]. Stock Performance - Hologic shares have declined approximately 19.3% since the beginning of the year, while the S&P 500 has decreased by 5.3% [3]. - The current Zacks Rank for Hologic is 3 (Hold), indicating expected performance in line with the market in the near future [6]. Future Outlook - The consensus EPS estimate for the upcoming quarter is$ 1.10 on revenues of $1.03 billion, and for the current fiscal year, it is$ 4.27 on revenues of $4.08 billion [7]. - The outlook for the industry, particularly the Medical - Instruments sector, is favorable, ranking in the top 23% of over 250 Zacks industries [8].